Skip to main content
HR 5845 114th Congress House

Budgeting for Opioid Addiction Treatment Act

Official title: To amend the Internal Revenue Code of 1986 to establish an excise tax on the production and importation of opioid pain relievers, and for other purposes.

Introduced: July 14, 2016 Introduced by: Larson, John B. Democratic · Connecticut See on congress.gov
Health CancerCongressional oversightDrug trafficking and controlled substancesDrug, alcohol, tobacco use
More subjectsShow fewer subjects
Health care coverage and accessHealth programs administration and fundingHealth promotion and preventive careLong-term, rehabilitative, and terminal carePrescription drugsSales and excise taxes
This bill died when the 114th Congress ended
It never became law before the 114th Congress (2015–2016) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 14, 2016
Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jul 14, 2016
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 14, 2016

Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

 Plain-English summary Congressional Research Service

Budgeting for Opioid Addiction Treatment Act

This bill amends the Internal Revenue Code to impose a one cent per milligram excise tax on the sale of active opioids by the manufacturer, producer, or importer. The tax excludes prescription drugs used exclusively for the treatment of opioid addiction as part of a medically assisted treatment effort.

The Department of Health and Human Services (HHS) must establish a program to provide rebates or discounts to cancer and hospice patients to ensure that they do not pay the tax.

The bill amends the Public Health Service Act to require any increase in federal revenues from the tax after rebates and discounts are subtracted to be distributed to states under the Substance Abuse Prevention and Treatment Block Grant program to be used exclusively for substance abuse (including opioid abuse) efforts in the states, including specified treatment programs.

HHS must report to Congress on the impact of this bill on the retail cost of opioids and patient access to opioid medication, the effectiveness of the discount or rebate for cancer and hospice patients, how the funds are being used to improve substance abuse treatment efforts, and suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 5845: Budgeting for Opioid Addiction Treatment Act. 114th Congress. Open America. https://openamerica.io/bill/114-HR-5845/
MLA
"H.R. 5845: Budgeting for Opioid Addiction Treatment Act." 114th Congress, 2026, Open America, https://openamerica.io/bill/114-HR-5845/.
Bluebook (legal)
H.R. 5845, 114th Cong. (2026), https://openamerica.io/bill/114-HR-5845/.
Markdown link
[H.R. 5845: Budgeting for Opioid Addiction Treatment Act](https://openamerica.io/bill/114-HR-5845/)
Report a problem